UK markets close in 5 hours 14 minutes

Regeneron Pharmaceuticals, Inc. (REGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
955.76-14.21 (-1.46%)
At close: 04:00PM EDT
950.00 -5.76 (-0.60%)
After hours: 07:30PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts23232626
Avg. Estimate10.6311.8944.2447.96
Low estimate9.2710.439.8740.97
High estimate12.8614.3151.5361.37
Year ago EPS10.2411.5943.7944.24
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts20192626
Avg. Estimate3.38B3.56B13.85B14.97B
Low estimate3.15B3.34B13.29B13.92B
High estimate3.5B3.75B14.42B16.86B
Year ago salesN/A3.36B13.12B13.85B
Sales growth (year/est)N/A5.80%5.60%8.00%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS9.8410.7210.7310.09
Actual EPS10.2411.5911.869.55
Difference0.40.871.13-0.54
Surprise %4.10%8.10%10.50%-5.40%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate10.6311.8944.2447.96
7 days ago10.891245.1347.65
30 days ago10.9411.9444.8647.36
60 days ago10.9511.8544.6447.11
90 days ago11.0611.944.9147.09
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days1223
Up last 30 days46712
Down last 7 daysN/AN/AN/AN/A
Down last 30 days7775
Growth estimatesREGNIndustrySector(s)S&P 500
Current qtr.3.80%N/AN/AN/A
Next qtr.2.60%N/AN/AN/A
Current year1.00%N/AN/AN/A
Next year8.40%N/AN/AN/A
Next 5 years (per annum)9.90%N/AN/AN/A
Past 5 years (per annum)17.45%N/AN/AN/A